Aier Eye Hospital Group Co., Ltd. (SHE:300015)
China · Delayed Price · Currency is CNY 8.00
+0.01 (0.13%)
Sep 16, 2026, 3:04 PM CST
Aier Eye Hospital Group Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 22,791 | 22,353 | 20,983 | 20,367 | 16,110 | 15,001 |
Revenue Growth | 3.86% | 6.53% | 3.02% | 26.43% | 7.39% | 25.93% |
Gross Profit Gross Profit Growth | 10,450 | 10,530 | 10,096 | 10,345 | 8,129 | 7,788 |
Operating Income Operating Income Growth | 4,887 | 4,695 | 4,455 | 5,223 | 3,887 | 4,022 |
Net Income Net Income Growth | 2,546 | 3,240 | 3,556 | 3,359 | 2,524 | 2,323 |
Earnings Per Share EPS Growth | 0.27 | 0.35 | 0.38 | 0.36 | 0.28 | 0.26 |
EPS Growth | -28.61% | -9.12% | 5.95% | 30.33% | 8.57% | 32.82% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Medical Industry Medical Industry Growth | 22,720 | 22,281 | 20,910 | 20,313 | 16,069 | 14,973 |
Unallocated Other Business Unallocated Other Business Growth | - | 71.58 | 72.83 | 54.3 | 41.12 | 27.91 |
Total Total Growth | 22,791 | 22,353 | 20,983 | 20,367 | 16,110 | 15,001 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 6,718 | 6,351 | 6,090 | 6,910 | 6,904 | 4,702 |
Total Debt Total Debt Growth | 7,671 | 7,217 | 6,780 | 5,600 | 4,555 | 5,476 |
Net Cash (Debt) Net Cash Growth | -952.48 | -866.46 | -690.13 | 1,310 | 2,349 | -773.24 |
Net Cash Growth | - | - | - | -44.23% | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.10 | -0.09 | -0.07 | 0.14 | 0.26 | -0.09 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 5,493 | 5,973 | 4,882 | 5,872 | 4,491 | 4,084 |
Capital Expenditures CapEx Growth | -1,806 | -2,093 | -1,830 | -1,460 | -1,388 | -1,494 |
Free Cash Flow Free Cash Flow Growth | 3,687 | 3,880 | 3,052 | 4,412 | 3,102 | 2,590 |
Free Cash Flow Growth | 0.47% | 27.15% | -30.84% | 42.22% | 19.79% | 5.72% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 45.85% | 47.11% | 48.12% | 50.79% | 50.46% | 51.92% |
Operating Margin | 21.44% | 21.00% | 21.23% | 25.64% | 24.13% | 26.81% |
Pretax Margin | 19.12% | 19.80% | 21.90% | 22.34% | 20.70% | 20.98% |
Profit Margin | 11.17% | 14.50% | 16.95% | 16.49% | 15.67% | 15.49% |
FCF Margin | 16.18% | 17.36% | 14.54% | 21.66% | 19.26% | 17.27% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.200 | 0.180 | 0.160 | 0.150 | 0.077 | 0.071 |
Dividend Per Share Growth | 12.48% | 12.48% | 6.67% | 95.09% | 8.31% | 3.65% |
Dividend Yield | 2.42% | 1.67% | 1.25% | 0.99% | 0.34% | 0.30% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 29.12 | 31.50 | 34.64 | 43.94 | 88.33 | 98.38 |
Forward PE | 20.25 | 25.00 | 33.20 | 35.69 | 67.40 | 89.50 |
P/FCF Ratio | 20.09 | 26.31 | 40.37 | 33.45 | 71.87 | 88.25 |
PS Ratio | 3.25 | 4.57 | 5.87 | 7.25 | 13.84 | 15.24 |